Corporate Information | Otsuka Medical Devices Co., Ltd.

Developing innovative treatment methods and creating new value

Otsuka Medical Devices Co., Ltd. was founded in February 2011 with a bold vision: to establish our medical device business as one of the Otsuka group’s core pillars supporting the total healthcare mission of the group. By leveraging the insights and technologies accumulated across the Otsuka group through pharmaceutical development, we develop, manufacture, and commercialize innovative medical devices worldwide. We also integrate global R&D efforts through collaboration with our group companies, Recor Medicaland Veryan Medical.
We will do what it takes to offer patients new innovative treatment choices, addressing medical needs yet to be fulfilled, creating new values, and contributing to the health and well-being of people around the world. We stay true to the Otsuka corporate philosophy: “Otsuka-people creating new products for better health worldwide”.

Otsuka Medical Devices Group Video

Message Video "Starting Out with a Dream"

Company Name	Otsuka Medical Devices Co., Ltd.
Established	February 15th, 2011
Capital	32.55 billion yen
Head Office	2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048, Japan
Tokyo Headquarters	Shinagawa Grand Central Tower 13F 2-16-4, Konan, Minato-ku, Tokyo 108-0075, Japan [Location]
Number of Employees	127 687 across Otsuka Medical Devices Group (As of December 31, 2025)
Business Description	R&D, manufacture, and sales of medical devices and all related operations, as well as medical device operational management for companies within the Otsuka group
Shareholder	Otsuka Holdings Co., Ltd. (100%)

Board of Directors

President and Representative Director	Noriko Tojo Profile　＋Open President and Representative Director, Otsuka Medical Devices Co., Ltd. Senior Executive Director and Board Member, Otsuka Holdings Co., Ltd. Previous Experience ・Executive Director and CEO, Pharmavite LLC ・President and CEO, Otsuka America, Inc. ・Began career in the financial industry, subsequently held executive roles in the consulting and technology sectors
Executive Deputy President	Kazumichi Kobayashi Profile　＋Open Executive Deputy President, Otsuka Medical Devices Co., Ltd. Advisor, Otsuka Holdings Co., Ltd. Previous Experience ・Founding Chairman and CEO, Otsuka Pharmaceutical Development and Commercialization, Inc. ・Senior Vice President, Associate General Manager of the Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd., where he also led Clinical Development, Regulatory Affairs, and Quality Assurance Divisions ・CEO, Otsuka Maryland Research Institute, Inc. ・Seconded to the Office of Pharmaceutical Industry Research as Chief Research Fellow (2012–2015)
Executive Director	Kuniaki Natsume
Executive Director	Toshihiro Tokumoto
Outside Director	Tomiko Tawaragi
Statutory Auditor	Yasuhiro Gomi
Senior Vice President	Christian Bell
Vice President	Ryoji Uchida
Vice President	Ryoji Sakai

(As of March 10, 2026)

History

February 2011	Otsuka Medical Devices is newly established as holding company for Otsuka group’s medical device activities including JIMRO Co., Ltd. (apheresis business) and Otsuka Pharmaceutical’s interests in MicroPort Scientific Corporation
October 2011	Acquisition of KiSCO Co., Ltd., a Japanese company specializing in spine and fractures
May 2016	Otsuka Holdings announces collaboration with ReCor Medical, Inc. regarding an equity investment and commercialization of ReCor’s ultrasound renal denervation technology in Asia
February 2017	Acquisition of Biomedical Solutions Inc., a Japanese venture designing novel stent retriever in ischemic stroke, through JIMRO Co., Ltd.
November 2018	ReCor Medical, Inc. becomes fully-owned subsidiary of Otsuka Medical Devices
December 2018	Veryan Medical Limited becomes fully-owned subsidiary of Otsuka Medical Devices
February 2022	Transferred KiSCO’s spine and trauma businesses to Teijin Nakashima Medical Co., Ltd.